Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.
    Difference
    11%
    Check dated 2025-10-05T09:53:59.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 (replacing v3.0.1) and the Back to Top element has been removed.
    Difference
    0.6%
    Check dated 2025-09-13T17:05:49.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T14:34:58.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    31%
    Check dated 2025-08-30T11:21:40.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:29:55.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.